| Phillip W Turner, MD | |
|
910 Wallace Ave, Leitchfield, KY 42754-2414 | |
| (270) 259-9400 | |
| (270) 259-0565 |
| Full Name | Phillip W Turner |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 49 Years |
| Location | 910 Wallace Ave, Leitchfield, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295790004 | NPI | - | NPPES |
| 64213010 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 21301 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Commonwealth Health Corporation Inc | 5496667628 | 221 |
News Archive
The measure, more than a year old, was initially put forth by Gov. Deval Patrick but the panel's chair predicted "a significant redraft" before it reaches the Senate flooor.
Stand Up To Cancer (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that the Allan H. (Bud) and Sue Selig Stand Up To Cancer Melanoma Innovative Research Grant Recipient Roger S. Lo, M.D., Ph.D., associate professor in the Department of Medicine at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles (UCLA) has published two studies in Cancer Discovery, a journal of the American Association for Cancer Research which indicate that treatment using combinatory therapy may be effective in suppressing drug resistance in the treatment of melanoma.
The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.
LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced the publication of results from a clinical study in the American Journal of Cardiology suggesting that despite having cholesterol levels considered acceptable by today's clinical standards, patients with Type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular disease-related events.
AIDS Healthcare Foundation will host a protest Wednesday morning, March 24th at 10:30am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, one of the most expensive first-line AIDS treatment in the US, during the Barclays Capital Global Healthcare Conference.
› Verified 7 days ago
| Entity Name | Commonwealth Health Corporation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881109304 PECOS PAC ID: 5496667628 Enrollment ID: O20040916000800 |
News Archive
The measure, more than a year old, was initially put forth by Gov. Deval Patrick but the panel's chair predicted "a significant redraft" before it reaches the Senate flooor.
Stand Up To Cancer (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that the Allan H. (Bud) and Sue Selig Stand Up To Cancer Melanoma Innovative Research Grant Recipient Roger S. Lo, M.D., Ph.D., associate professor in the Department of Medicine at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles (UCLA) has published two studies in Cancer Discovery, a journal of the American Association for Cancer Research which indicate that treatment using combinatory therapy may be effective in suppressing drug resistance in the treatment of melanoma.
The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.
LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced the publication of results from a clinical study in the American Journal of Cardiology suggesting that despite having cholesterol levels considered acceptable by today's clinical standards, patients with Type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular disease-related events.
AIDS Healthcare Foundation will host a protest Wednesday morning, March 24th at 10:30am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, one of the most expensive first-line AIDS treatment in the US, during the Barclays Capital Global Healthcare Conference.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Phillip W Turner, MD 910 Wallace Ave, Leitchfield, KY 42754-2414 Ph: (270) 259-9400 | Phillip W Turner, MD 910 Wallace Ave, Leitchfield, KY 42754-2414 Ph: (270) 259-9400 |
News Archive
The measure, more than a year old, was initially put forth by Gov. Deval Patrick but the panel's chair predicted "a significant redraft" before it reaches the Senate flooor.
Stand Up To Cancer (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that the Allan H. (Bud) and Sue Selig Stand Up To Cancer Melanoma Innovative Research Grant Recipient Roger S. Lo, M.D., Ph.D., associate professor in the Department of Medicine at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles (UCLA) has published two studies in Cancer Discovery, a journal of the American Association for Cancer Research which indicate that treatment using combinatory therapy may be effective in suppressing drug resistance in the treatment of melanoma.
The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.
LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced the publication of results from a clinical study in the American Journal of Cardiology suggesting that despite having cholesterol levels considered acceptable by today's clinical standards, patients with Type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular disease-related events.
AIDS Healthcare Foundation will host a protest Wednesday morning, March 24th at 10:30am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, one of the most expensive first-line AIDS treatment in the US, during the Barclays Capital Global Healthcare Conference.
› Verified 7 days ago
Dr. Eric C Brown, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 910 Wallace Ave, Leitchfield, KY 42754 Phone: 270-259-9400 Fax: 270-259-6110 | |
Darren B Lyle, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 Wallace Ave, Leitchfield, KY 42754 Phone: 270-259-1656 Fax: 270-259-9536 | |
Dr. Anthony Francis Filippone, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Shauna Dr, Leitchfield, KY 42754 Phone: 502-339-8000 | |
Dale L. Bruns, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 910 Wallace Ave, Leitchfield, KY 42754 Phone: 270-259-1656 Fax: 270-259-9536 |